{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:19:48Z","timestamp":1785449988302,"version":"3.56.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1038\/s41391-025-00941-4","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T16:02:14Z","timestamp":1737388934000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Best of 2024 in Prostate Cancer and Prostatic diseases"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2190-512X","authenticated-orcid":false,"given":"Cosimo","family":"De Nunzio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"key":"941_CR1","doi-asserted-by":"publisher","unstructured":"De Nunzio C, Salonia A, Gacci M, Ficarra V. Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia. World J Urol [Internet]. Springer Berlin Heidelberg; 2020;38:2771\u20139. Available from: https:\/\/doi.org\/10.1007\/s00345-020-03106-1","DOI":"10.1007\/s00345-020-03106-1"},{"key":"941_CR2","first-page":"359","volume":"86","author":"C De Nunzio","year":"2015","unstructured":"De Nunzio C, Brassetti A, Gacci M, Finazzi Agr\u00f2 E, Carini M, Presicce F, et al. Patients with prostatic inflammation undergoing transurethral prostatic resection have a larger early improvement of storage symptoms. Urology [Internet]. Urology. 2015;86:359\u201367. https:\/\/pubmed.ncbi.nlm.nih.gov\/26194294\/","journal-title":"Urology [Internet]. Urology"},{"key":"941_CR3","doi-asserted-by":"crossref","unstructured":"De Nunzio C, Kramer G, Marberger M, Montironi R, Nelson W, Schr\u00f6der F, et al. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation. Eur Urol [Internet]. 2011 [cited 2018 Apr 14];60:106\u201317. Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283811003629","DOI":"10.1016\/j.eururo.2011.03.055"},{"key":"941_CR4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/pcan.2012.44","volume":"16","author":"M Gacci","year":"2013","unstructured":"Gacci M, Vignozzi L, Sebastianelli A, Salvi M, Giannessi C, De Nunzio C, et al. Metabolic syndrome and lower urinary tract symptoms: the role of inflammation. Prostate Cancer Prostatic Dis [Internet]. Prostate Cancer Prostatic Dis. 2013;16:100\u20135. https:\/\/pubmed.ncbi.nlm.nih.gov\/23165431\/","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"941_CR5","unstructured":"Fang B, Lu Y, Li X, Wei Y, Ye D, Wei G, et al. Targeting the tumor microenvironment, a new therapeutic approach for prostate cancer [Internet]. Prostate Cancer Prostatic Dis Nature.; 2024 [cited 2024 Dec 14]. p. 1\u201310. Available from: https:\/\/www.nature.com\/articles\/s41391-024-00825-z"},{"key":"941_CR6","doi-asserted-by":"crossref","unstructured":"Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012;8:445\u2013544.","DOI":"10.4161\/auto.19496"},{"key":"#cr-split#-941_CR7.1","doi-asserted-by":"crossref","unstructured":"Wang X, Zhou L, Qi L, Zhang Y, Yin H, Gan Y, et al. High GLUT1 membrane expression and low PSMA membrane expression in Ductal Adenocarcinoma and Intraductal Carcinoma of the prostate. Prostate Cancer Prostatic Dis 2023 274 [Internet]. Nature Publishing Group","DOI":"10.1038\/s41391-023-00759-y"},{"key":"#cr-split#-941_CR7.2","unstructured":"2023 [cited 2024 Dec 14];27:720-7. Available from: https:\/\/www.nature.com\/articles\/s41391-023-00759-y"},{"key":"941_CR8","unstructured":"Mari A, Cadenar A, Giudici S, Cianchi G, Albisinni S, Autorino R, et al. A systematic review and meta-analysis to evaluate the diagnostic accuracy of PSMA PET\/CT in the initial staging of prostate cancer [Internet]. Prostate Cancer Prostatic Dis. 2024 [cited 2024 Dec 14]. p. 1\u201314. Available from: https:\/\/www.nature.com\/articles\/s41391-024-00850-y"},{"key":"941_CR9","unstructured":"Nicoletti R, Alberti A, Castellani D, Yee CH, Zhang K, Poon DMC, et al. Functional outcomes and safety of focal therapy for prostate cancer: a systematic review on results and patient-reported outcome measures (PROMs) [Internet]. Prostate Cancer Prostatic Dis. 2023 [cited 2024 Jan 4]. p. 1\u20139. Available from: https:\/\/www.nature.com\/articles\/s41391-023-00698-8"},{"key":"941_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.eururo.2021.08.005","volume":"81","author":"JS Hopstaken","year":"2022","unstructured":"Hopstaken JS, Bomers JGR, Sedelaar MJP, Valerio M, F\u00fctterer JJ, Rovers MM. An updated systematic review on focal therapy in localized prostate cancer: what has changed over the past 5 years? Eur Urol [Internet]. Eur Urol. 2022;81:5\u201333. https:\/\/pubmed.ncbi.nlm.nih.gov\/34489140\/","journal-title":"Eur Urol [Internet]. Eur Urol"},{"key":"941_CR11","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.annonc.2020.06.011","volume":"31","author":"C Parker","year":"2020","unstructured":"Parker C, Castro E, Fizazi K, Heidenreich A, Ost P, Procopio G, et al. Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol [Internet]. Ann Oncol. 2020;31:1119\u201334. https:\/\/pubmed.ncbi.nlm.nih.gov\/32593798\/","journal-title":"Ann Oncol Off J Eur Soc Med Oncol [Internet]. Ann Oncol"},{"key":"941_CR12","doi-asserted-by":"crossref","unstructured":"Cocci A, Pezzoli M, Lo Re M, Russo GI, Asmundo MG, Fode M, et al. Quality of information and appropriateness of ChatGPT outputs for urology patients [Internet]. Prostate Cancer Prostatic Dis. 2023 [cited 2024 Jun 15]. p. 159\u201360. Available from: https:\/\/www.nature.com\/articles\/s41391-023-00754-3","DOI":"10.1038\/s41391-023-00754-3"},{"key":"941_CR13","doi-asserted-by":"crossref","unstructured":"Balestrazzi E, Paciotti M, Piro A, Piramide F, Bravi CA, Peraire Lores M, et al. Comparative analysis of robot-assisted simple prostatectomy: the HUGOTM RAS system versus the DaVinci\u00ae Xi system. Prostate Cancer Prostatic Dis. 2023 [cited 2024 Jan 4];1\u20137. Available from: https:\/\/www.nature.com\/articles\/s41391-023-00726-7","DOI":"10.1038\/s41391-023-00726-7"},{"key":"941_CR14","doi-asserted-by":"crossref","unstructured":"Mossack SM, Franco A, Roadman DF, Sturgis MR, Orsini A, Bignante G, et al. Social determinants of health and surgical outcomes of minimally invasive radical prostatectomy: a national population-based study. Prostate Cancer Prostatic Dis. 2024 [cited 2024 Dec 14];1\u20136. Available from: https:\/\/www.nature.com\/articles\/s41391-024-00913-0","DOI":"10.1038\/s41391-024-00913-0"},{"key":"941_CR15","doi-asserted-by":"crossref","unstructured":"Busetto GM, Lombardo R, De Nunzio C, Santoro G, Tocci E, Schiavone N, et al. Ejaculation sparing of classic and minimally invasive surgical treatments of LUTS\/BPH [Internet]. Prostate Cancer Prostatic Dis. 2024 [cited 2024 Dec 14]. p. 1\u20138. Available from: https:\/\/www.nature.com\/articles\/s41391-024-00834-y","DOI":"10.1038\/s41391-024-00834-y"},{"key":"941_CR16","doi-asserted-by":"crossref","unstructured":"Gemma L, Pecoraro A, Sebastianelli A, Spatafora P, Sessa F, Nicoletti R, et al. Impact of minimally invasive surgical procedures for Male Lower Urinary Tract Symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review [Internet]. Prostate Cancer Prostatic Dis. 2024 [cited 2024 Dec 14]. p. 404\u201321. Available from: https:\/\/www.nature.com\/articles\/s41391-024-00795-2","DOI":"10.1038\/s41391-024-00795-2"},{"key":"941_CR17","doi-asserted-by":"crossref","unstructured":"Secco S, Olivero A, Longoni M, Dell\u2019Oglio P, Tappero S, Dibilio E, et al. Use of a Schelin catheter for transurethral intraprostatic anesthesia (TUIA) prior to iTIND procedure. Prostate Cancer Prostatic Dis. 2024 [cited 2024 Dec 14];1\u20132. Available from: https:\/\/www.nature.com\/articles\/s41391-024-00892-2","DOI":"10.1038\/s41391-024-00892-2"},{"key":"941_CR18","doi-asserted-by":"crossref","unstructured":"Sibona M, Destefanis P, Vercelli E, Secco S, Gontero P, Cindolo L. Ejaculation physiology and dysfunction after BPH surgery: the role of the new MISTs [Internet]. Prostate Cancer Prostatic Dis. 2023 [cited 2024 Jan 4]. p. 475\u201382. Available from: https:\/\/www.nature.com\/articles\/s41391-023-00686-y","DOI":"10.1038\/s41391-023-00686-y"},{"key":"941_CR19","doi-asserted-by":"crossref","unstructured":"Lemos G, Fernandes CMADS, Silva FH, Calmasini FB. The role of autophagy in prostate cancer and prostatic diseases: a new therapeutic strategy. Prostate Cancer Prostatic Dis. Springer US; 2024;27:230\u20138.","DOI":"10.1038\/s41391-024-00793-4"},{"key":"941_CR20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nrurol.2016.168","volume":"13","author":"C De Nunzio","year":"2016","unstructured":"De Nunzio C, Presicce F, Tubaro A. Inflammatory mediators in the development and progression of benign prostatic hyperplasia. Nat Rev Urol. 2016;13:613\u201326.","journal-title":"Nat Rev Urol"},{"key":"941_CR21","doi-asserted-by":"publisher","first-page":"50904","DOI":"10.18632\/oncotarget.15144","volume":"8","author":"C De Nunzio","year":"2017","unstructured":"De Nunzio C, Giglio S, Stoppacciaro A, Gacci M, Cirombella R, Luciani E, et al. Autophagy deactivation is associated with severe prostatic inflammation in patients with lower urinary tract symptoms and benign prostatic hyperplasia. Oncotarget [Internet]. 2017;8:50904\u201310. Impact Journals LLC [cited 2020 Sep 25]; Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28881614\/","journal-title":"Oncotarget [Internet]"},{"key":"941_CR22","doi-asserted-by":"crossref","unstructured":"Roudsari NM, Lashgari NA, Momtaz S, Abaft S, Jamali F, Safaiepour P, et al. Inhibitors of the PI3K\/Akt\/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention. Pharmaceutics [Internet]. Pharmaceutics; 2021 [cited 2024 Dec 16];13. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34452154\/","DOI":"10.3390\/pharmaceutics13081195"},{"key":"941_CR23","first-page":"7993","volume":"14","author":"A Al-Qatati","year":"2017","unstructured":"Al-Qatati A, Aliwaini S. Combined pitavastatin and dacarbazine treatment activates apoptosis and autophagy resulting in synergistic cytotoxicity in melanoma cells. Oncol Lett [Internet]. Oncol Lett. 2017;14:7993\u20139. [cited 2024 Dec 16] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29344241\/","journal-title":"Oncol Lett [Internet]. Oncol Lett"},{"key":"941_CR24","doi-asserted-by":"crossref","unstructured":"Chen C, Wang H, Geng X, Zhang D, Zhu Z, Zhang G, et al. Metformin exerts anti-AR-negative prostate cancer activity via AMPK\/autophagy signaling pathway. Cancer Cell Int [Internet]. Cancer Cell Int; 2021 [cited 2024 Dec 16];21. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34399755\/","DOI":"10.1186\/s12935-021-02043-2"},{"key":"941_CR25","doi-asserted-by":"crossref","unstructured":"De Nunzio C, Lombardo R, Tema G, Cancrini F, Russo GI, Chacon R, et al. Mobile phone apps for the prediction of prostate cancer: External validation of the Coral and Rotterdam apps. Eur J Surg Oncol [Internet]. W.B. Saunders Ltd; 2019 [cited 2020 Apr 3];45:471\u20136. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30343993","DOI":"10.1016\/j.ejso.2018.09.018"},{"key":"941_CR26","first-page":"364.e1","volume":"36","author":"C De Nunzio","year":"2018","unstructured":"De Nunzio C, Lombardo R, Tema G, Alkhatatbeh H, Gandaglia G, Briganti A, et al. External validation of Chun, PCPT, ERSPC, Kawakami, and Karakiewicz nomograms in the prediction of prostate cancer: A single center cohort-study. Urol Oncol Semin Orig Investig. 2018;36:364.e1\u2013364.e7.","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"941_CR27","doi-asserted-by":"publisher","unstructured":"De Nunzio C, Lombardo R, Cindolo L, Bertolo R, Minervini A, Muto G, et al. Rotterdam mobile phone app including MRI data for the prediction of prostate cancer: A multicenter external validation. Eur Urol Open Sci [Internet]. Elsevier; 2020;19:e1732\u20133. Available from: https:\/\/doi.org\/10.1016\/S2666-1683(20)33759-9","DOI":"10.1016\/S2666-1683(20)33759-9"},{"key":"941_CR28","doi-asserted-by":"publisher","unstructured":"Denijs FB, van Harten MJ, Meenderink JJL, Leenen RCA, Remmers S, Venderbos LDF, et al. Risk calculators for the detection of prostate cancer: a systematic review. Prostate Cancer Prostatic Dis [Internet]. Springer US; 2024;27:544\u201357. Available from: https:\/\/doi.org\/10.1038\/s41391-024-00852-w","DOI":"10.1038\/s41391-024-00852-w"},{"key":"941_CR29","unstructured":"Zattoni F, Gandaglia G, van den Bergh RCN, Marra G, Valerio M, Martini A, et al. Follow-up on patients with initial negative mpMRI target and systematic biopsy for PI-RADS \u2265 3 lesions - an EAU-YAU study enhancing prostate cancer detection. Prostate Cancer Prostatic Dis [Internet]. Prostate Cancer Prostatic Dis. 2024 [cited 2024 Dec 14]; Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39501078\/"},{"key":"941_CR30","doi-asserted-by":"publisher","unstructured":"Hagens MJ, Luining WI, Boev\u00e9 LMS, Knol RJJ, Roeleveld TA, Srbljin S, et al. The appropriateness of PSMA PET\/CT in newly diagnosed unfavorable intermediate-risk prostate cancer patients\u2014towards a tumor volume-based risk stratification. Prostate Cancer Prostatic Dis [Internet]. Springer US; 2024;9\u201311. Available from: https:\/\/doi.org\/10.1038\/s41391-024-00899-9","DOI":"10.1038\/s41391-024-00899-9"},{"key":"941_CR31","doi-asserted-by":"publisher","unstructured":"Freedland SJ, Gao W, Lax A, Yang H, Ramaswamy K, Russell D, et al. Real-world outcomes following biochemical recurrence after definitive therapy with a short prostate-specific antigen doubling time: potential role of early secondary treatment. Prostate Cancer Prostatic Dis [Internet]. Springer US; 2024;1\u20138. Available from: https:\/\/doi.org\/10.1038\/s41391-024-00894-0","DOI":"10.1038\/s41391-024-00894-0"},{"key":"941_CR32","doi-asserted-by":"publisher","unstructured":"Shoji S, Naruse J, Ohno S, Aoki M, Takahashi K, Yuzuriha S, et al. Focal therapy using high-intensity focused ultrasound with intraoperative prostate compression for patients with localized prostate cancer: a multi-center prospective study with 7 year experience. Prostate Cancer Prostatic Dis [Internet]. Springer US; 2024;1\u20137. Available from: https:\/\/doi.org\/10.1038\/s41391-024-00921-0","DOI":"10.1038\/s41391-024-00921-0"},{"key":"941_CR33","doi-asserted-by":"crossref","unstructured":"Lombardo R, Gallo G, Stira J, Turchi B, Santoro G, Riolo S, et al. Quality of information and appropriateness of Open AI outputs for prostate cancer. Prostate Cancer Prostatic Dis [Internet]. Springer Nature; 2024 [cited 2024 Dec 14]; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/38228809","DOI":"10.1038\/s41391-024-00789-0"},{"key":"941_CR34","first-page":"138","volume":"76","author":"P Geretto","year":"2024","unstructured":"Geretto P, Lombardo R, Albisinni S, Turchi B, Campi R, DE Cillis S, et al. Quality of information and appropriateness of ChatGPT outputs for neuro-urology. Minerva Urol Nephrol. Edizioni Minerva Medica. 2024;76:138\u201340.","journal-title":"Minerva Urol Nephrol. Edizioni Minerva Medica"},{"key":"941_CR35","doi-asserted-by":"crossref","unstructured":"Puerto Nino AK, Garcia Perez V, Secco S, De Nunzio C, Lombardo R, Tikkinen KAO, et al. Can ChatGPT provide high-quality patient information on male lower urinary tract symptoms suggestive of benign prostate enlargement? Prostate Cancer Prostatic Dis [Internet]. Springer Nature; 2024 [cited 2024 Dec 14]; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/38871841","DOI":"10.1038\/s41391-024-00847-7"},{"key":"941_CR36","doi-asserted-by":"crossref","unstructured":"Puerto Nino AK, Garcia Perez V, Secco S, De Nunzio C, Lombardo R, Tikkinen KAO, et al. Reply to RE: Can ChatGPT provide high-quality patient information on male lower urinary tract symptoms suggestive of benign prostate enlargement? Prostate Cancer Prostatic Dis [Internet]. Springer Nature; 2024 [cited 2024 Dec 14]; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/39085590","DOI":"10.1038\/s41391-024-00877-1"},{"key":"941_CR37","doi-asserted-by":"crossref","unstructured":"Hershenhouse JS, Mokhtar D, Eppler MB, Rodler S, Storino Ramacciotti L, Ganjavi C, et al. Accuracy, readability, and understandability of large language models for prostate cancer information to the public. Prostate Cancer Prostatic Dis. Springer US; 2024;1\u20136.","DOI":"10.1038\/s41391-024-00826-y"},{"key":"941_CR38","doi-asserted-by":"crossref","unstructured":"Franco A, Ditonno F, Manfredi C, Pellegrino AA, Licari LC, Bologna E, et al. Single port robot-assisted radical and simple prostatectomy: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. Springer US; 2024;1\u201312.","DOI":"10.1038\/s41391-024-00787-2"},{"key":"941_CR39","doi-asserted-by":"publisher","unstructured":"Lambertini L, Sandulli A, Coco S, Paganelli D, Cadenar A, Dell\u2019Oglio P, et al. Complication rate across the minimally invasive surgical treatments (MISTs): where do we stand? A systematic review of the literature. Prostate Cancer Prostatic Dis [Internet]. Springer US; 2024;1\u201313. Available from: https:\/\/doi.org\/10.1038\/s41391-024-00900-5","DOI":"10.1038\/s41391-024-00900-5"},{"key":"941_CR40","doi-asserted-by":"publisher","unstructured":"Kaplan SA, Moss JL, Freedman SJ Two-year long-term follow-up of treatment with the Optilume BPH catheter system in a randomized controlled trial for benign prostatic hyperplasia (The PINNACLE Study). Prostate Cancer Prostatic Dis [Internet]. Springer US; 2024;27:531\u20136. Available from: https:\/\/doi.org\/10.1038\/s41391-024-00833-z","DOI":"10.1038\/s41391-024-00833-z"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-00941-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-00941-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-00941-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T07:59:12Z","timestamp":1740470352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-00941-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["941"],"URL":"https:\/\/doi.org\/10.1038\/s41391-025-00941-4","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,20]]},"assertion":[{"value":"16 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CDN is Editor in Chief of the journal.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}